NCT03942952 2023-09-05
SONICS
University of Texas Southwestern Medical Center
Completed
Clinical Trials
11 trialsNCT02003144 2022-08-23
An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients
Alexion Pharmaceuticals, Inc.
Phase 3 Completed
NCT02144935 2022-08-23
TMCAPTURE
University of Texas Southwestern Medical Center
Completed
NCT03336762 2021-01-11
ISCoPE-TM
St George's, University of London
Completed
NCT00304291 2020-12-28
A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)
State University of New York at Buffalo
Phase 4 Completed
NCT02591901 2020-03-18
PReSuTINeB
Buckinghamshire Healthcare NHS Trust
Phase 2 Completed
NCT02276963 2019-06-06
Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses
Johns Hopkins University
Phase 1 Completed
NCT02341950 2019-02-22
Clinical Trial of a Serious Game for Individuals With SCI/D
University of Michigan
Phase NA Completed
NCT03138421 2019-01-25
Central Pain Study for ABX-1431
Abide Therapeutics
Phase 1 Completed
NCT00179478 2017-09-06
CHAMPIONS10
Beth Israel Deaconess Medical Center
Phase 4 Completed
NCT00501748 2011-09-27
Safety and Tolerability of Rituximab in Neuromyelitis Optica
University of California, San Francisco
Phase 1 Completed